Actively Recruiting
Stress Urinary Incontinence for Female Patients (CGM MUIT-2301)
Led by Ceragem Clinical Inc. · Updated on 2026-02-27
96
Participants Needed
1
Research Sites
93 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multicenter, prospective, randomized, double-blind, sham-controlled clinical trial conducted in female patients with stress urinary incontinence.
CONDITIONS
Official Title
Stress Urinary Incontinence for Female Patients (CGM MUIT-2301)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients with urine leakage of 1 gram or more on the standardized pad test
You will not qualify if you...
- Patients with mixed urinary incontinence with predominant urgency urinary incontinence
- Patients with stress urinary incontinence
- Patients with overflow urinary incontinence
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Samsung Seoul Hospital
Seoul, South Korea
Actively Recruiting
Research Team
M
Myeongbae Shin, Researcher
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here